Exicure (XCUR) Interest Coverage Ratio (2016 - 2025)
Exicure's (XCUR) quarterly Interest Coverage Ratio came in at 20.7 in Q4 2025, down 227.0% YoY from 16.3 in Q4 2024, and down 189.92% on a QoQ basis from 23.02 in Q2 2025.
Exicure (XCUR) Interest Coverage Ratio (2016 - 2025) Analysis & Trends
Exicure (XCUR) has 10 years of Interest Coverage Ratio data on file, last reported at 20.7 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 227.0% year-over-year to 20.7 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 38.83 (down 286.38% YoY) and the FY2025 annual result came in at 0.55, up 69.05% from the prior year.
- Interest Coverage Ratio declined to 20.7 in Q4 2025, from 23.02 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 448.3 in Q4 2021 to a low of 2494.33 in Q2 2022.
- A 5-year average of 195.34 and a median of 10.58 in 2021 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio jumped 1603.93% — and 2022, when it slumped 23472.19%.
- Tracing XCUR's Interest Coverage Ratio over 5 years: stood at 448.3 in 2021, then tumbled by 656.4% to 2494.33 in 2022, then jumped by 99.72% to 7.03 in 2023, then climbed by 9.92% to 6.33 in 2024, then tumbled by 227.0% to 20.7 in 2025.
- The last three Interest Coverage Ratio figures came in at 20.7 (Q4 2025), 23.02 (Q2 2025), and 26.82 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.70 |
| Jun 30, 2025 | 23.02 |
| Mar 31, 2025 | 26.82 |
| Dec 31, 2024 | -6.33 |
| Sep 30, 2024 | -214.33 |
| Jun 30, 2024 | -205.83 |
| Mar 31, 2023 | -7.03 |
| Jun 30, 2022 | -2,494.33 |
| Mar 31, 2022 | -8.87 |
| Dec 31, 2021 | 448.30 |
| Sep 30, 2021 | -50.73 |
| Jun 30, 2021 | -10.58 |
| Mar 31, 2021 | -18.79 |
| Dec 31, 2020 | -29.81 |
| Sep 30, 2020 | -337.78 |
| Mar 31, 2020 | 3.76 |
| Dec 31, 2019 | -39.18 |
| Sep 30, 2019 | -28.72 |
| Jun 30, 2019 | -24.55 |
| Mar 31, 2019 | -20.14 |